The traditional method for monitoring ER expression level is immunohistochemical staining with tumor biopsy samples in vitro, which is an invasive technique and cannot reflect the real-time ER expression level of primary and metastatic breast cancer or other tissues. This evidence concerns the gene ESR1 and neoplasm.